About Artivion
Artivion (NYSE:AORT) specializes in medical technology focusing on a variety of surgical solutions and patient care innovations. The company is deeply involved in the research, development, and distribution of medical devices that address the needs of cardiovascular and neurological surgeries. Through its advanced products and services, Artivion aims to improve clinical outcomes for patients, enabling healthier lives and improved recovery times. A significant part of its mission is to continually invest in new technologies and projects that push the boundaries of medical science, ensuring that healthcare professionals have access to the latest advancements in medical procedures. With a commitment to excellence and innovation, Artivion strives to lead in the creation and delivery of groundbreaking care solutions that make a real difference in people’s lives.
Snapshot
Operations
Produtos e/ou serviços de Artivion
- CryoValve SG pulmonary heart valve, a decellularized human valve designed to replace a diseased, damaged, or malfunctioning heart valve.
- PhotoFix bovine pericardium patch, treated with glutaraldehyde for durable cardiac and vascular repairs.
- BioGlue surgical adhesive, designed for cardiac and vascular surgical procedures, offering a unique solution for tissue adherence and sealing.
- Aortic Stent Grafts: These are minimally invasive devices used to repair weakened or damaged sections of the aorta, the major artery that carries blood away from the heart.
- On-X Mechanical Heart Valves: These valves are implanted to replace diseased aortic or mitral valves in the heart.
- AMDS™ Hybrid Prosthesis: This device is a minimally invasive option for repairing aneurysms of the aortic arch, the topmost section of the aorta.
equipe executiva do Artivion
- Mr. James Patrick MackinChairman, President & CEO
- Mr. Lance A. Berry CPAEVP, COO, CFO & Treasurer
- Ms. Jean F. Holloway Esq.Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
- Mr. John E. DavisSenior VP & Chief Commercial Officer
- Dr. Marshall S. Stanton M.D.Senior VP of Clinical Research & Chief Medical Officer
- Ms. Amy D. Horton CPAVP & Chief Accounting Officer
- Mr. Matthew A. GetzVP of Human Resources & Chief Human Resources Officer
- Mr. Jason D. AsperSenior VP and Chief Strategy & Digital Officer
- Dr. Robert C. Thomson Ph.D.Vice President of Research & Development